Biomaterials-based Germinal Center Niches for Understanding the B Cell Maturation and B cell receptor signaling
Biomaterials-based Germinal Center Niches for Understanding the B Cell Maturation and B cell receptor signaling
批准号:
10222176
负责人:
Ankur Singh
金额:
$31.61万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-02-09 至 2023-01-31
关键词:
AffinityAnimal ModelAntibodiesAntibody AffinityAntibody-Producing CellsAntigensApoptosisAreaArthritisAsthmaB Cell ProliferationB cell differentiationB-Cell ActivationB-Cell DevelopmentB-LymphocytesBindingBiocompatible MaterialsCD40 LigandCell AdhesionCell CycleCell Cycle Checkpoint GenesCell MaturationCellsChronic DiseaseCommunitiesComplexCyclin-Dependent Kinase InhibitorDevelopmentDifferentiation AntigensDiseaseEngineeringEnhancersEpigenetic ProcessExtracellular MatrixFollicular Dendritic CellsGenerationsGoalsGraft RejectionHematopoietic NeoplasmsHistonesHomologous GeneHumoral ImmunitiesImmuneImmune responseImmune signalingImmunizationImmunoglobulin-Secreting CellsImmunologyInfectionIntegrin alpha4beta1IntegrinsInvestigationKineticsKnockout MiceKnowledgeLigandsLinkLymphoidLymphoid TissueLysineMediatingMedicineMethylationMethyltransferaseModelingMultiple MyelomaMusMutateNatureOrganoidsPathway interactionsPhenotypePhysiologyPlasma CellsPolycombPolyethylene GlycolsPopulationProcessProliferatingProteinsProtocols documentationPsoriatic ArthritisRGD (sequence)ReactionReceptor SignalingReceptors, Antigen, B-CellRecyclingReportingResearchRoleScientistSignal TransductionSpecificitySpleenStructure of germinal center of lymph nodeSurfaceT-LymphocyteTherapeutic AgentsTimeTissue EngineeringTissue ModelTissuesTransgenic MiceTransgenic OrganismsTumor Necrosis Factor Ligand Superfamily Member 6Workbasecombinatorialcytokinedesignexperimental studyextracellularfightinghistone methyltransferaseimprovedin vivoin vivo Modelknock-downleukemia/lymphomalymph nodesmalignant breast neoplasmmouse modelmultidisciplinaryresponsesecondary lymphoid organ
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Antibodies are routinely used as therapeutic agents to fight a wide range of disorders including asthma, blood
cancers, breast cancer, arthritis, and transplant rejection. Humoral immunity against infections depends on the
germinal center (GC) differentiation process in the B cell follicles of secondary lymphoid organs, such as
spleen and lymph nodes. In GCs, B cells rapidly proliferate and somatically mutated high-affinity antibody
secreting cells, i.e. plasma cells, are generated from naïve B cells in response to T cell-dependent antigen. To
date, the scientific community has relied on animal models to generate high-affinity antibodies and discover
fundamental knowledge of GC immunology. Yet scientists are far from understanding the extracellular and
intracellular factors that contribute to the exuberant pace of the GC reaction and conversion to antibody
secreting cells (ASCs). Recent in vivo studies have uncovered crucial signals such as CD40 ligand (CD40L)
from T cells, B cell activation factor from follicular dendritic cells, cytokines, and integrin ligands from the
surrounding lymphoid niche, that are required for the induction of GCs and selection of high-affinity cells.
Developing biomaterials to recapitulate the process of generating high affinity, antigen specific antibodies ex
vivo via the GC process could enable more rapid development of antibodies for use in the treatment of a
number of chronic diseases. Such tissue models can also be used to improve the mechanistic investigation
into signaling and epigenetic mechanisms that regulate GC B cells. The goal of this study is not to recapitulate
all aspects of an in vivo model, but rather to generate a model that will inform the natural process in vivo, and
also the development antigen-specific ASCs ex vivo. The specific aims will focus on engineering designer
organoids with tunable ligand specificities, understanding the antigen specific immune response, and establish
a link between integrin ligand specificity and cell cycle epigenetics of GC reaction.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Tissue-engineered Aged B Cell Immune Organoid to Study Antibody Secreting Cell Differentiation Trajectory
-
批准号:10804886
-
项目类别:
-
资助金额:$32.43万
-
财政年份:2023
-
负责人:Ankur Singh
-
依托单位:
Dysregulated mechanoimmunology of epigenetics-driven lymphomas
-
批准号:10669928
-
项目类别:
-
资助金额:$53.26万
-
财政年份:2023
-
负责人:Ankur Singh
-
依托单位:
Engineered ImmuneChip Platform to Study B cell Migration and Affinity Maturation
-
批准号:10206458
-
项目类别:
-
资助金额:$18.14万
-
财政年份:2021
-
负责人:Ankur Singh
-
依托单位:
Engineered ImmuneChip Platform to Study B cell Migration and Affinity Maturation
-
批准号:10331889
-
项目类别:
-
资助金额:$22.05万
-
财政年份:2021
-
负责人:Ankur Singh
-
依托单位:
Lymphoid Experimental Therapeutics Platform to Study Cooperative Signaling inHuman Lymphomas
-
批准号:10656239
-
项目类别:
-
资助金额:$42.17万
-
财政年份:2020
-
负责人:Ankur Singh
-
依托单位:
Lymphoid Experimental Therapeutics Platform to Study Cooperative Signaling inHuman Lymphomas
-
批准号:10427259
-
项目类别:
-
资助金额:$45.18万
-
财政年份:2020
-
负责人:Ankur Singh
-
依托单位:
Lymphoid Experimental Therapeutics Platform to Study Cooperative Signaling inHuman Lymphomas
-
批准号:10206067
-
项目类别:
-
资助金额:$47.36万
-
财政年份:2020
-
负责人:Ankur Singh
-
依托单位:
Lymphoid Experimental Therapeutics Platform to Study Cooperative Signaling inHuman Lymphomas
-
批准号:9885752
-
项目类别:
-
资助金额:$48.93万
-
财政年份:2020
-
负责人:Ankur Singh
-
依托单位:
Biomaterials-based Germinal Center Niches for Understanding the B Cell Maturation and B cell receptor signaling
-
批准号:10247830
-
项目类别:
-
资助金额:$36.8万
-
财政年份:2018
-
负责人:Ankur Singh
-
依托单位:
Biomaterials-based Germinal Center Niches for Understanding the B Cell Maturation and B cell receptor signaling
-
批准号:10330042
-
项目类别:
-
资助金额:$36.01万
-
财政年份:2018
-
负责人:Ankur Singh
-
依托单位:
LETSSGo: Lymphoma-on-chip Engineered Technology for Single-Organoid Sequencing and Genomics
-
批准号:9233420
-
项目类别:
-
资助金额:$37.12万
-
财政年份:2017
-
负责人:Ankur Singh
-
依托单位:
海外基金